2-amino-6-(4-hydroxy-2-oxo-2H-chromen-3-yl)-4-(3-methoxyphenyl)nicotinonitrile

ID: ALA4868909

PubChem CID: 164625158

Max Phase: Preclinical

Molecular Formula: C22H15N3O4

Molecular Weight: 385.38

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1cccc(-c2cc(-c3c(O)c4ccccc4oc3=O)nc(N)c2C#N)c1

Standard InChI:  InChI=1S/C22H15N3O4/c1-28-13-6-4-5-12(9-13)15-10-17(25-21(24)16(15)11-23)19-20(26)14-7-2-3-8-18(14)29-22(19)27/h2-10,26H,1H3,(H2,24,25)

Standard InChI Key:  ZHSQXZZMKDUQLK-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
    1.0474   -5.9446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0462   -6.7720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7616   -7.1827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7598   -5.5298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4757   -5.9410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4764   -6.7679    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1923   -7.1767    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9078   -6.7640    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9030   -5.9341    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1867   -5.5248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6084   -5.5169    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3262   -5.9290    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0381   -5.5107    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0336   -4.6849    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3111   -4.2791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6021   -4.6954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3037   -3.4568    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0163   -3.0360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0088   -2.2119    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2894   -1.8075    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5761   -2.2291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5871   -3.0519    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6203   -7.1716    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1823   -4.6998    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.7452   -4.2702    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4571   -3.8505    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.7554   -5.9213    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.7154   -1.7941    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.4305   -2.1972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
  9 11  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 17  1  0
 15 17  1  0
  8 23  2  0
 10 24  1  0
 25 26  3  0
 14 25  1  0
 13 27  1  0
 19 28  1  0
 28 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4868909

    ---

Associated Targets(Human)

A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
WI-38 (2654 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KDR Tclin Vascular endothelial growth factor receptor 2 (20924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDGFRB Tclin Platelet-derived growth factor receptor beta (5195 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FGFR3 Tclin Fibroblast growth factor receptor (331 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 385.38Molecular Weight (Monoisotopic): 385.1063AlogP: 3.69#Rotatable Bonds: 3
Polar Surface Area: 122.37Molecular Species: ACIDHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 5.96CX Basic pKa: 0.84CX LogP: 2.98CX LogD: 1.54
Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.52Np Likeness Score: -0.49

References

1. Ahmed EY, Elserwy WS, El-Mansy MF, Serry AM, Salem AM, Abdou AM, Abdelrahman BA, Elsayed KH, Abd Elaziz MR..  (2021)  Angiokinase inhibition of VEGFR-2, PDGFR and FGFR and cell growth inhibition in lung cancer: Design, synthesis, biological evaluation and molecular docking of novel azaheterocyclic coumarin derivatives.,  48  [PMID:34246754] [10.1016/j.bmcl.2021.128258]

Source